circadian rhythm raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic small molecule | Studied as a REV-ERB agonist |
| Molecular formula | C20H24ClN3O4S | Reported for the neutral compound |
| Appearance | Off-white to pale yellow solid | Typical research-grade material |
| Solubility | Sparingly soluble in water | Soluble in solvents such as DMSO |
| Common synonyms | SR9009; Stenabolic | Stenabolic is an informal alias |
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
=== Early applications === In 1903, Ludwig Roselius popularized the use of benzene to decaffeinate coffee. This discovery led to the production of Sanka. This process was later discontinued. Benzene was historically used as a significant component in many consumer products such as liquid wrench, several paint strippers, rubber cements, spot removers, and other products. Manufacture of some of these benzene-containing formulations ceased in about 1950, although Liquid Wrench continued to contain significant amounts of benzene until the late 1970s.
In March and April 2025, FIFA unveiled a set of 16 posters representing each of the 2026 World Cup host cities. The posters, designed by local artists, were intended to reflect the "distinct identity and heritage" of each city. On March 3, 2026, the official poster for the tournament was unveiled. It was created by Carson Ting of Canada, Minerva GM of Mexico, and Hank Willis Thomas of the United States.
Kennedy, E P (2001), "Hitler's gift and the era of biosynthesis", J. Biol. Chem., vol. 276, no. 46 (published Nov 16, 2001), pp. 42619–31, doi:10.1074/jbc.R100051200, PMID 11559714 Young, V R; Ajami, A (1999), "The Rudolf Schoenheimer Centenary Lecture. Isotopes in nutrition research", The Proceedings of the Nutrition Society, vol. 58, no. 1 (published Feb 1999), pp. 15–32, doi:10.1079/pns19990004, PMID 10343336 Olson, R E (1997), "The dynamic state of body constituents (Schoenheimer, 1939)", J. Nutr., vol. 127, no. 5 Suppl (published May 1997), pp. 1041S–1043S, PMID 9164302 Guggenheim, K Y (1991), "Rudolf Schoenheimer and the concept of the dynamic state of body constituents.", J. Nutr., vol. 121, no. 11 (published Nov 1991), pp. 1701–4, doi:10.1093/jn/121.11.1701, PMID 1941176 Ratner, S; Rittenberg, D; Keston, A S; Schoenheimer, R (1987), "The Journal of Biological Chemistry, Volume 134, June 1940: Studies in protein metabolism. XIV. The chemical interaction of dietary glycine and body proteins in rats. By S. Ratner, D. Rittenberg, Albert S. Keston, and Rudolf Schoenheimer", Nutr. Rev., vol. 45, no. 10 (published Oct 1987), pp. 310–2, doi:10.1111/j.1753-4887.1987.tb06338.x, PMID 3320825 Shemin, D (1987), "On the impact on biochemical research of the discovery of stable isotopes: the outcome of the serendipic meeting of a refugee with the discoverer of heavy isotopes at Columbia University", Anal. Biochem., vol. 161, no. 2 (published Mar 1987), pp.
Sources: en.wikipedia.org
Devro plc is a multinational company with a registered office in Moodiesburn, Chryston, Scotland which manufactures and distributes goods derived from collagen, principally Sausage casings, a product in which it is the world leader. The firm also produces films, casings, and other specialised collagen products for use in the healthcare and cosmetics industries. The company was acquired by SARIA in 2023.
The longest-lived isotope, 247Cm, has half-life 15.6 million years; so any primordial curium, that is, present on Earth when it formed, would have decayed to undetectable levels by now. However, recent nearby sites of R-process nucleosynthesis process can generate 247Cm and 247Cm has been detected in geologic samples from deep ocean floor drill cores . Its past presence as an extinct radionuclide is detectable as an excess of its primordial, long-lived daughter 235U. Traces of 242Cm may occur naturally in uranium minerals due to neutron capture and beta decay (238U → 239Pu → 240Pu → 241Am → 242Cm), though the quantities would be tiny and this has not been confirmed: even with "extremely generous" estimates for neutron absorption possibilities, the quantity of 242Cm present in 1 × 108 kg of 18% uranium pitchblende would not even be one atom. Traces of 247Cm are also probably brought to Earth in cosmic rays, but this also has not been confirmed. There is also the possibility of 244Cm being produced as the double beta decay daughter of natural 244Pu. Curium is made artificially in small amounts for research purposes. It also occurs as one of the waste products in spent nuclear fuel. Curium is present in nature in some areas used for nuclear weapons testing.
Augustus exiled his daughter Julia, guilty of "excessive sentimental vivacity", to Reggio. In 61 Paul the Apostle passed through Reggio on his way to Rome. Christianity spread in Calabria to the port centers and along the Via Popilia, vital areas of the Roman region. Emperor Trajan opened the Via Traiana during his rule, roughly traced by State Road 18 Tirrena halfway up the coast. In 305 Calabrian patrician Bulla rebelled against the Roman Empire with 600 horsemen and 5,000 infantry. He was defeated by the imperial militia, but Rome never fully controlled the forests of Sila. On October 1, 313 Constantine I promulgated the Edict of Milan in favor of Christianity, which began to spread. In 391 Emperor Theodosius I proclaimed Christianity the state religion. In 363 Basil the Great landed in Caesarea. His disciples founded various monasteries and cenobia beginning in the ninth century, laying the foundations of the Calabrian-Greek monastic tradition. In 365 an earthquake accompanied by a tidal wave shook the southern Mediterranean, affecting Calabria's coastal towns. The Roman Empire split into two branches. The Western branch, ruled by Honorius with its capital in Ravenna, suffered in 410 the invasion of Alaric's Visigoths, who sacked Rome and marched south. Legend has it that Alaric died in Cosenza, buried at the confluence of the Crati and Busento under the two rivers.
==== Information laundering ==== Generative AI has been noted for its use by state-sponsored propaganda campaigns in information laundering. According to a 2025 report by Graphika, generative AI is used to launder articles from Chinese state media such as China Global Television Network through various social media sites in an attempt to disguise the articles' origin.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.
No. SR9009 is frequently mislabeled as a SARM in online discussions, but it does not target androgen receptors. Its known mechanism involves REV-ERB nuclear receptors and circadian-metabolic gene regulation.
Human clinical data are very limited. There is no approved human use, and safety and efficacy in people are not established. Most evidence comes from preclinical models, so effects observed in animals may not apply to humans.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.